Curasen Therapeuticsincis A Biopharmaceutical Company Focused On Developing Innovativetreatments For Neurodegenerativediseasesthecompany Aims Torethink Brain Diseaseby Addressing Early Vulnerabilities In Neurodegenerationparticularly Through Theadrenergic Systemwhich Is Essential For Cognitivefunctions Likeattentionmemoryand Mood Curasen S Pipelinefeatures Several Candidatesincluding Cst 10 And Cst 20 2Which Arei 2 Adrenoceptor Agonists In Phase2 Clinical Studiesadditionallycst 056An I 1A Adrenoceptor Agonistis In Phase1 Trials For Alzheimer S Diseasethecompany Also Offers Fixed Dosecombinationscuracn And Curaxndesigned To Tacklecognitivedeclineand Neurological Symptoms In Conditions Such As Major Depressivedisorder And Alzheimer S Diseasecurasen Is Supported By Strategic Investments From Organizations Likethealzheimer S Drug Discovery Foundationunderscoring Its Commitment To Advancing Treatments For Neurodegenerativediseasesthecompany Provides Career Opportunities In Various Fields Related To Biopharmaceutical Development
